Peptit-Majör Histokompatibilite Kompleks I Tetramerleri ile Antijen Spesifik CD8+ T Hücrelerinin Hedeflenmesi ve Aktivasyonu
Tez Türü: Doktora
Tezin Yürütüldüğü Kurum: Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü, Temel Onkoloji A.B.D., Türkiye
Tez Danışmanı: Hande Canpınar
Tezin Onay Tarihi: 2025
Tezin Dili: İngilizce
Desteklendiği Program: Diğer
Özet:
T lymphocytes are key players in immune
defense, recognizing tumor or infected cells through T-cell receptors (TCRs) that bind
peptide–MHC (pMHC) complexes. However, this interaction is often too weak for
effective detection of antigen-specific T cells. To enhance binding avidity, multimeric
pMHC molecules are used, but traditional tetramerization strategies may miss TCRs
recognizing low-stability yet immunogenic peptides. Moreover, in vivo use is limited
by the need to engineer new pMHC constructs for each peptide, posing time and cost
challenges. This thesis introduces a modular strategy using sortase-mediated ligation
and azide–alkyne click chemistry to generate stable pMHC complexes. An azide group
was added to β2-microglobulin near the peptide-binding cleft, and peptides with a
poly-glycine spacer and alkyne group were covalently linked. The resulting complexes
showed high TCR binding and stability for over three months at 4 °C without free
peptide. This system notably stabilized SIINYEKL, a weak MHC binder. Additionally,
costimulatory dimeric pMHC constructs were developed using nanobody technology
and mammalian expression. While structurally successful, these constructs did not
promote expected T cell proliferation. Further optimization is needed. Overall, this
work presents a flexible platform for detecting and activating antigen-specific T cells
with potential in personalized immunotherapy.